Rituximab is an Effective Treatment in Patients with Pemphigus Vulgaris and Demonstrates a Steroid-Sparing Effect.

CONCLUSIONS: In patients with moderate to severe PV, rituximab plus short-term prednisone was more effective than prednisone alone. Rituximab-treated patients had less CS exposure and were less likely to experience severe or life-threatening CS-related AEs. This article is protected by copyright. All rights reserved. PMID: 31487383 [PubMed - as supplied by publisher]

https://www.ncbi.nlm.nih.gov/pubmed/31487383?dopt=Abstract

Source: The British Journal of Dermatology - September 4, 2019 Category: Dermatology Authors: Chen DM, Odueyungbo A, Csinady E, Gearhart L, Lehane P, Cheu M, Maho-Vaillant M, Prost-Squarcioni C, Hebert V, Houivet E, Calbo S, Caillot F, Golinski ML, Labeille B, Picard-Dahan C, Paul C, Richard MA, Bouaziz JD, Duvert-Lehembre S, Bernard P, Caux F, Al Tags: Br J Dermatol Source Type: research